Evidence map›Paper›PMID 38124331›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2024

FMR1 Carriers Report Executive Function Changes Prior to Fragile X-Associated Tremor/Ataxia Syndrome: A Longitudinal Study.

David Hessl, Karina Mandujano Rojas, Emilio Ferrer, Glenda Espinal, Jessica Famula, Andrea Schneider, Randi Hagerman, Flora Tassone, Susan M Rivera

Open access · hybridAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cognitive-behavioral phenotypes inFrontiers in molecular neuroscience · 2026
    Article
  7. Article
  8. Article
  9. Long-read sequencing reveals extensivebioRxiv : the preprint server for biology · 2025
    Article
  10. Premutation Females with preFXTAS.International journal of molecular sciences · 2025
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

David HesslMIND Institute, University of California Davis Health, Sacramento, California, USA.ORCID 0000-0002-3460-9805
Karina Mandujano RojasMIND Institute, University of California Davis Health, Sacramento, California, USA.ORCID 0000-0001-8445-2167
Emilio FerrerDepartment of Psychology, University of California Davis, Davis, California, USA.ORCID 0000-0001-7520-046X
Glenda EspinalMIND Institute, University of California Davis Health, Sacramento, California, USA.
Jessica FamulaMIND Institute, University of California Davis Health, Sacramento, California, USA.ORCID 0000-0002-2858-6897
Andrea SchneiderMIND Institute, University of California Davis Health, Sacramento, California, USA.ORCID 0000-0002-4674-7244
Randi HagermanMIND Institute, University of California Davis Health, Sacramento, California, USA.ORCID 0000-0001-5029-8448
Flora TassoneMIND Institute, University of California Davis Health, Sacramento, California, USA.ORCID 0000-0002-6388-9180
Susan M RiveraMIND Institute, University of California Davis Health, Sacramento, California, USA.ORCID 0000-0002-4870-4774
UC Davis Health · USUniversity of California, Davis · US

Funding

GENOTYPE/PHENOTYPE RELATIONSHIPS IN FRAGILE X FAMILIESR01HD036071 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI PAUL J HAGERMAN, RANDI J. HAGERMAN · 1998 to 2026
$13.8M
Research Project: Pathologic Significance of Maternal AutoantibodiesP50HD103526 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEONARD J. ABBEDUTO, Melissa Dawn Bauman · 2020 to 2026
$9.7M
Trajectories and Markers of Neurodegeneration in Fragile X Premutation CarriersR01MH078041 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HESSL, DAVID R, RIVERA, SUSAN M · 2007 to 2017
$5.4M
Trajectories and Markers of Neurodegeneration in Fragile X Premutation CarriersR01NS110100 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DAVID R HESSL, Susan M Rivera · 2018 to 2026
$5.4M
NICHD NIH HHS P50 HD103526NICHD NIH HHS R01 HD036071NIMH NIH HHS R01 MH078041NINDS NIH HHS R01 NS110100
6 · The paper itself

Abstract

backgroundMen with fragile X-associated tremor/ataxia syndrome (FXTAS) often develop executive dysfunction, characterized by disinhibition, frontal dyscontrol of movement, and working memory and attention changes. Although cross-sectional studies have suggested that earlier executive function changes may precede FXTAS, the lack of longitudinal studies has made it difficult to address this hypothesis.

objectiveTo determine whether executive function deterioration experienced by premutation carriers (PC) in daily life precedes and predicts FXTAS.

methodsThis study included 66 FMR1 PC ranging from 40 to 78 years (mean, 59.5) and 31 well-matched healthy controls (HC) ages 40 to 75 (mean, 57.7) at baseline. Eighty-four participants returned for 2 to 5 follow up visits over a duration of 1 to 9 years (mean, 4.6); 28 of the PC developed FXTAS. The Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) was completed by participants and their spouses/partners at each visit.

resultsLongitudinal mixed model regression analyses showed a greater decline with age in PC compared to HC on the Metacognition Index (MI; self-initiation, working memory, organization, task monitoring). Conversion to FXTAS was associated with worsening MI and Behavioral Regulation Index (BRI; inhibition, flexibility, emotion modulation). For spouse/partner report, FXTAS conversion was associated with worsening MI. Finally, increased self-report executive function problems at baseline significantly predicted later development of FXTAS.

conclusionsExecutive function changes experienced by male PC represent a prodrome of the later movement disorder. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

Fragile X SyndromeMovement DisordersAdultAtaxiaCross-Sectional StudiesExecutive FunctionFragile X Messenger Ribonucleoprotein 1HumansLongitudinal StudiesMaleTremorFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1attentionCGG‐repeatexecutive dysfunctionFMR1 genefragile Xfragile x‐associated tremor/ataxia syndromeinhibitory controlneurodegenerationtrinucleotide repeatworking memory

Identifiers

PMID38124331
PMCPMC11268876
OpenAlexW4390055324

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.